SCHEMBL17969740

SCHEMBL17969740

Fc1ccc(Cl)c(CN2CCNc3c2cc2n3-c3nc(N4CCCC4)ccc3-2)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 6/20 0.44
JAK2 O60674 2/20 0.44
PRKD3 O94806 2/20 0.44
MAP4K4 O95819 2/20 0.44
ABL1 P00519 2/20 0.44
LCK P06239 2/20 0.44
CSF1R P07333 2/20 0.44
RET P07949 2/20 0.44
MET P08581 2/20 0.44
FGFR1 P11362 2/20 0.44
LTK P29376 2/20 0.44
FLT3 P36888 2/20 0.44
PTK2 Q05397 2/20 0.44
MAP4K2 Q12851 2/20 0.44
NTRK2 Q16620 2/20 0.44
TAOK1 Q7L7X3 2/20 0.44
AURKB Q96GD4 2/20 0.44
MAP4K5 Q9Y4K4 2/20 0.44
PLK4 O00444 1/20 0.44
ROS1 P08922 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17969737 0.76 ALK (0.41) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL16615199 0.72 ALK (0.61) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL17969728 0.71 ALK (0.49) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL16615360 0.71 ALK (0.57) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL16615321 0.69 ALK (0.48) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL20859322 0.69 ALK (0.47) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL20859356 0.66 ALK (0.41) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL1600322 0.66 ALK (0.69) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL16615286 0.64 ALK (0.49) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL16615292 0.64 ALK (0.46) ALKJAK2PRKD3MAP4K4ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050884-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES Limited Liability Company "National Pharmaceutical (RU) 2016-08-03 EP disclosed